Tumors of the testis and paratesticular structures: Introduction: Germ cell tumors: Intratubular germ cell neoplasia, unclassified (IGCNU): Seminomas: Non Seminomatous and mixed germ cell tumors: Tumors of sex cord gonadal stroma: Miscellaneous tumors of the testis

Clinical Pathology of Urological Tumours

Volumn , Issue , 2007, Pages 161-214

  Mikuz, Gregor ^a   Colecchia, Maurizio ^b  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85146630393     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (259)

1. Pugh RCB. Testicular tumors-introduction. In: Pugh RCB, ed. Pathology of the Testis. Oxford, London, Edinburgh Melbourne: Blackwell Scientific Publications: 1976; 139-59.
2. Eble JN, Sauter G, Epstein JI, Sesterhenn IA, eds. WHO Classification of tumors. Pathology & Genetics. Tumors of the Urinary System and Male Genital Organs. Lyon, France: IARCPress; 2004; 218-9.
3. Collins DH, Pugh RC. Classification and frequency of testicular tumors. Br J Urol 1964; 36 (Suppl): 1-11.
4. Skakkebaek NE. Possible carcinoma in situ of the testis. Lancet 1972; 2: 516-17.
5. Mostofi FK, Sobin LH. Histological Typing of Tumors of the Testis. International Histological classification of tumors, No 16. Geneva, Switzerland: WHO, 1977.
6. von Hochstetter AR, Hedinger CE. The differential diagnosis of testicular germ cell tumors in theory and practice. A critical analysis of two major systems of classifiction and review of 389 cases. Virch Arch A Pathol Anat Histol 1982; 396: 247-77.
7. Stiens R. Testikuläre Keimzelltumoren: Histologie, Klassifikation, Pathologie und Häufigkeit. In: Weißbach L, Hildenbrand G, eds. Register und Verbundstudie für Hodentumoren-Bonn. Ergebnisse einer prospektiven Untersuchung. München: W Zuckschwerdt Verlag, 1982; 27-50.
8. Jacobsen KG, Barlebo H, Olsen J et al. Testicular germ cell tumors in Denmark 1976-1980. Pathology of 1058 consecutive cases. Acta Radiol Oncol 1984; 23: 239-47.
9. Horwich A, Shipley J, Huddart R. Testicular germ-cell cancer. Lancet. 2006; 367: 754-65.
10. Rajpert-De Meyts E. Developmental model for the pathogenesis of testicular carcinoma in situ: genetic and environmental aspects. Hum Reprod Update 2006; 12: 303-23.
11. Almstrup K, Ottesen AM, Sonne SB et al. Genomic and gene expression signature of the pre-invasive testicular carcinoma in situ. Cell Tissue Res 2005; 322: 159-65.
12. Kraggerud SM, Berner A, Bryne M et al. Spermatocytic seminoma as compared to classical seminoma: an immunohistochemical and DNA flow cytometric study. APMIS 1999; 107: 297-302.
13. Giwercman A, Cantell L, Marks A. Placental-like alkaline phosphatase as a marker of carcinoma-in-situ of the testis. Comparison with monoclonal antibodies M2A and 43-9F. APMIS 1991; 99: 586-94.
14. Skotheim RI, Lothe RA. The testicular germ cell tumor genome. APMIS 2003; 111: 136-50.
15. Spierings DC, de Vries EG, Vellenga E et al. The attractive Achilles heel of germ cell tumors: an inherent sensitivity to apoptosis-inducing stimuli. J Pathol. 2003; 200: 137-48.
16. Ferlay J, Bray F, Pisani P et al. GLOBOOCAN 2002 Cancer Incidence, Mortality and Prevalence Worldwide. Lyon, France: IARC Press; 2004.
17. Purdue MP, Devesa SS, Sigurdson AJ et al. International patterns and trends in testis cancer incidence. Int J Cancer 2005; 115: 822-7.
18. McGlynn KA, Devesa SS, Sigurdson AJ et al. Trends in the incidence of testicular germ cell tumors in the United States. Cancer 2003; 97: 63-70.
19. McGlynn KA, Devesa SS, Graubard BI et al. Increasing incidence of testicular germ cell tumors among black men in the United States. J Clin Oncol 2005; 23: 5757-61.
20. Leonard MP, Jeffs RD, Leventhal B et al. Pediatric testicular tumors: the Johns Hopkins experience. Urology 1991; 37: 253-6.
21. Dieckmann KP, Pichlmeier U. Clinical epidemiology of testicular germ cell tumors. World J Urol 2004; 22: 2-14.
22. Herrinton LJ, Zhao W, Husson G. Management of cryptorchism and risk of testicular cancer. Am J Epidem 2002; 157: 602-5.
23. Moller H, Prener A, Skakkebaek NE. Testicular cancer, cryptorchidism, inguinal hernia, testicular atrophy, and genital malformations: case control studies in Denmark. Cancer Causes Control 1996; 7: 264-74.
24. Pike MC, Chilvers C, Peckham MJ. Effect of age at orchidopexy on risk of testicular cancer. Lancet 1986; 1: 1246-8.
25. Raina V, Shukla NK, Gupta NP et al. Germ cell tumors in uncorrected cryptorchid testis at Institute Rotary Cancer Hospital, New Delhi. Br J Cancer 1995; 71: 380-2.
26. Skakkebaek NE, Rajpert-De Meyts E, Main KM. Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum Reprod 2001; 16: 972-8.
27. Den Hond E, Schoeters G. Endocrine disrupters and human puberty. Int J Androl 2006; 29: 264-71.
28. Sharp RM. The 'oestrogen hypothesis'-where do we stand now? Int J Androl 2002; 26: 2-15.
29. Tabernero J, Paz-Ares L, Salazar R et al. Incidence of contralateral germ cell testicular tumors in South Europe: report of the experience at 2 Spanish university hospitals and review of the literature. J Urol 2004; 171: 164-7.
30. Czene K, Lichtenstein P, Hemminki P Enviromental and heritable causes of cancer among 9.6 milllion individuals in the Swedish Family-Cancer Database. Int J Cancer 2002; 99: 260-6.
31. Hemminki K, Chen B. Familial risks in testicular cancer as aetiological clues. Int J Androl 2006; 29: 205-10.
32. Heimdal K, Olsson H, Tretli S et al. Familial testicular cancer in Norway and southern Sweden. Br J Cancer 1996; 73: 964-9.
33. Rapley EA, Crockford GP, Easton DF et al. International Testicular Cancer Linkage Consortium. Localisation of susceptibility genes for familial testicular germ cell tumor. APMIS 2003; 111: 128-33.
34. Manuel M, Katayama PK, Jones HW Jr. The age of occurrence of gonadal tumors in intersex patients with a Y chromosome. Am J Obstet Gynecol 1976; 124: 293-300.
35. Nathanson KL, Kanetsky PA, Hawes R et al. The Y deletion gr/gr and susceptibility to testicular germ cell tumor. Am J Hum Genet 2005; 77: 1034-43.
36. Fend F, Hittmair A, Rogatsch H et al. Seminomas positive for Epstein-Barr virus by the polymerase chain reaction: viral RNA transcripts (Epstein-Barr-encoded small RNAs) are present in intratumoral lymphocytes but absent from the neoplastic cells. Mod Pathol 1995; 8: 622-5.
37. Guo J, Pukkala E, Kyyronen P et al. Testicular cancer, occupation and exposure to chemical agents among Finnish men in 1971-1995. Cancer Causes Control 2005; 16: 97-103.
38. Mills PK, Newell GR, Johnson DE. Testicular cancer associated with employment in agriculture and oil and natural gas extraction. Lancet 1984; 1: 207-10.
39. Davies JM. Testicular cancer in England and Wales: some epidemiological aspects. Lancet 1981; 1: 928-32.
40. Pukkala E, Weiderpass E. Socio-economic differences in incidence rates of cancers of the male genital organs in Finland, 1971-95. Int J Cancer 2002; 102: 643-8.
41. Kim B, Winter TC 3rd, Ryu JA. Testicular microlithiasis: clinical significance and review of the literature. Eur Radiol 2003; 13: 2567-76.
42. Loy V, Dieckmann KP. Prevalence of contralateral testicular intraepithelial neoplasia (carcinoma in situ) in patients with testicular germ cell tumor. Results of the German multicentre study. Eur Urol 1993; 23: 120-2.
43. Sigg C, Hedinger CE. Atypical germ cells of the testis. Comparative ultrastructural and immunohistochemical investigations. Virch Arch [A] 1983; 402: 439-50.
44. Dieckmann KP, Skakkebaek NE. Carcinoma in situ of the testis: review of biological and clinical features. Int J Cancer 1999; 83: 815-22.
45. Armstrong GR, Buckley CH, Kelsey AM. Germ- cell expression of placental alkaline phosphatase in male pseudohermaphroditism. Histopathology 1991; 18: 541-7.
46. Coffin CM, Ewing S, Dehner LP. Frequency of intratubulär germ cell neoplasia with invasive germ cell tumors. Histologic and immunocytochemical features. Arch Pathol Lab Med 1985; 109: 555-9.
47. Daugaard G, von der Maase H, Olsen et al. Carcinoma-in-situ testis in patients with assumed extragonadal germ-cell tumors. Lancet 1987; 2: 528-30.
48. Hailelemariam S, Engler DS, Bannwart F et al. Primary mediastinal germ cell tumor with intratubulär germ cell neoplasia of the testis-further support for germ cell origin of these tumors: a case report. Cancer 1997; 79: 1031-6.
49. el-Naggar AK, Ro JY, McLemore D et al. DNA ploidy in testicular germ cell neoplasms. Histogenetic and clinical implications. Am J Surg Pathol 1992; 16: 611-18.
50. Looijenga LH, Rosenberg C, van Gurp RJ et al. Comparative genomic hybridization of microdissected samples from different stages in the development of a seminoma and a non-seminoma. J Pathol 2000; 191: 187-92.
51. Rosenberg C, Van Gurp RJ, Geelen E et al. Overrepresentation of the short arm of chromosome 12 is related to invasive growth of human testicular seminomas and nonseminomas. Oncogene 2000; 19: 5858-62.
52. von der Maase H, Rorth M, Walbom-Jorgensen S et al. Carcinoma in situ of contralateral testis in patients with tesicular germ cell cancer: study of 27 cases in 500 patients. Br Med J 1986; 293: 1398-401.
53. Dieckmann KP, Loy V, Buttner P. Prevalence of bilateral testicular germ cell tumors and early detection based on contralateral intraepithelial neoplasia. Br J Urol 1993; 71: 340-5.
54. Dieckmann KP, Classen J, Loy V. Diagnosis and management of testicular intraepithelial neoplasia (carcinoma in situ)-surgical aspects. APMIS 2003; 111: 64-8.
55. Grigor KM, Rorth M. Should the contralateral testis be biopsied? Round table discussion. Eur Urol 1993; 23: 129-35.
56. Herr HW, Sheinfeld J. Is biopsy of the contralateral testis necessary in patients with germ cell tumors? J Urol 1997; 158: 1331-4.
57. Christensen TB, Daugaard G, Geertsen PF et al. Effect of chemotherapy on carcinoma in situ of the testis. Ann Oncol 1998; 9: 657-60.
58. McGlynn KA, Devesa SS, Sigurdson AJ et al. Trends in the incidence of testicular germ cell tumors in the United States. Cancer 2003; 97: 63-70.
59. Kay R. Prepubertal testicular tumor registry. J Urol 1993; 150: 671-4.
60. Thackray AC, Crane WAJ. Seminoma. In: Pugh RCB, eds. Pathology of the Testis, Oxford London, Edinburgh Melbourne: Blackwell Scientific Publications, 1976; 164-98.
61. Mikuz G, Kiesler J, Scheiber K et al. Morphology and incidence of testicular tumors in western Austria (1945-1980). Zentralbl Allg Pathol 1984; 129: 91-100.
62. von Hochstetter AR Mitotic count in seminomas-an unreliable criterion for distinguishing between classical and anaplastic types. Virch Arch [A] 1981; 390: 63-9.
63. Damjanov I, Niejadlik DC, Rabuffo JV et al. Cribriform and sclerosing seminoma devoid of lymphoid infiltrates. Arch Pathol Lab Med 1980; 104: 527-30.
64. Young RH, Finlayson N, Scully RE Tubular seminoma. Report of a case. Arch Pathol Lab Med 1989; 113: 414-16.
65. Mostofi FK, Sesterhenn IA. Pathology of germ cell tumors of testes. Prog Clin Biol Res 1985; 203: 1-34.
66. Zuckman MH, Williams G, Lewin HS. Mitosis counting in seminoma: an exercise of questionable significance. Hum Pathol 1980; 19: 329-35.
67. Hori K, Uematsu K, Yasoshima H et al. Contribution of cell proliferative activity to malignancy potential in testicular seminoma. Pathol Int 1997; 47: 282-7.
68. http://www.Immunoquery.com (Immunohistochemistry Literature Database Query System).
69. Hittmair A, Rogatsch H, Hobisch A et al. CD30 expression in seminoma. Hum Pathol 1996; 27: 1166-71.
70. Hittmair A, Rogatsch H, Feichtinger H et al. Testicular seminomas are aneuploid tumors. Lab Invest 199; 72: 70-4.
71. van Echten J, Osterhuis JW, Looijenga LH et al. No recurrent structural abnormalities apart from i(12p) in primary germ cell tumors of the adult testis. Genes Chromosomes Cancer 1995; 14: 133-44.
72. Castedo SM, de Jong B, Osterhuis JW et al. Cytogenetic analysis of human seminomas. Cancer Res 1989; 49: 5696-570.
73. Warde P, Specht L, Horwich A et al. Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis. J Clin Oncol 2002; 20: 4448-52.
74. Tyldesley S, Voduc D, McKenzie M et al. Surveillance of stage I testicular seminoma: British Columbia Cancer Agency Experience 1992 to 2002. Urology 2006; 67: 594-8.
75. Parker C, Milosevic M, Panzarella T et al. The prognostic significance of the tumor infiltrating lymphocyte count in stage I testicular seminoma managed by surveillance. Eur J Cancer 2002; 38: 2014-19.
76. Josefsen D, Fossa S. The management strategies for stage I seminoma. Clin Oncol (R Coll Radiol) 2005; 17: 539-42.
77. Aparicio J, Germa JR, Garcia del Muro X et al. Risk-adapted management for patients with clinical stage I seminoma: the Second Spanish Germ Cell Cancer Cooperative Group study. J Clin Oncol 2005; 23: 8717-23.
78. Hernes EH, Harstad K, Fossa SD. Changing incidence and delay of testicular cancer in southern Norway (1981-1992). Eur Urol 1996; 30: 349-57.
79. Patterson H, Norman A, Mitra SS et al. Combination carboplatin and radiotherapy in the managment of Stage II testicular seminoma: comparison with radiotherapy alone. Radiother Oncol 2001; 59: 5-11.
80. Masson P, étude sur le séminome. Rev Canad Biol 1946; 5: 361-87.
81. Jacobsen GK, Barlebo H, Olsen J et al. Testicular germ cell tumors in Denmark 1976-1980. Pathology of 1058 consecutive cases. Acta Radiol Oncol 1984; 109: 938-42.
82. Eble JN. Spermatocytic seminoma. Hum Pathol 1994; 25: 1035-42.
83. Talerman A. Spematocytic seminoma: clinicopathological study of 22 cases. Cancer 1980; 45: 2169-76.
84. Verdorfer I, Rogatsch H, Tzankov A et al. Molecular cytogenetic analysis of human spermatocytic seminomas. J Pathol 2004; 204: 277-81.
85. Burke AP, Mostofi FK. Placental alkaline phosphatase immunohistochemistry of intratubular malignant germ cells and associated testicular germ cell tumors. Hum Pathol 1988; 19: 663-70.
86. Rosai J, Khodadoust K, Silber I. Spermatocytic seminoma. II. Ultrastructural study. Cancer 1969; 24: 103-16.
87. Albores Saavedra J, Huffman H, Alvarado-Cabrero I et al. Anaplastic variant of spermatocytic seminoma. Hum Pathol 1996; 27: 650-5.
88. Kraggerud SM, Berner A, Bryne M et al. Spermatocytic seminoma as compared to classical seminoma: an immunohistochemical and DNA flow cytometric study. APMI 1999; 107: 297-302.
89. Cummings OW, Ulbright TM, Eble JN et al. Spermatocytic seminoma: an immunohistochemical study. Hum Pathol 1994; 25: 54-9.
90. Steiner H, Gozzi C, Verdorfer I et al. Metastatic spermatocytic seminoma-an extremely rare disease. Eur Urol 2006; 49: 183-6.
91. Chung PW, Bayley AJ, Sweet J et al. Spermatocytic seminoma: a review. Eur Urol 2004; 45: 495-8.
92. Moriyama N, Daly JJ, Keating MA et al. Vascular invasion as a prognosticator of metastatic disease in nonseminomatous germ cell tumors of the testis. Importance in 'surveillance only' protocols. Cancer 1985; 56: 2492-8.
93. Delozier-Blanchet CD, Walt H, Engel E et al. Cytogenetic studies of human testicular germ cell tumors. Int J Androl 1987; 10: 69-77.
94. Spiess PE, Brown GA, Liu P et al. Predictors of outcome in patients undergoing postchemotherapy retroperitoneal lymph node dissection for testicular cancer. Cancer 2006; 107: 1483-90.
95. Mostofi FK, Sesterhenn IA, Davis CJ Jr. Developments in histopathology of testicular germ cell tumors. Semin Urol 1988; 6: 171-88.
96. Williams SD, Einhorn LH. Neoplasms of the testis. In: Calabresi P, Schein PS, Rosenberg SA, eds: Medical Oncology: Basic Principles and Clinical Management of Cancer. New York: Macmillan, 1985; 1077-88.
97. Teilum G, Endodermal sinus tumor of the ovary and testis. Cancer 1959; 12: 1092-105.
98. Brosman SA. Testicular tumors in prepubertal children. Urology 1979; 13: 581-8.
99. Niehans GA, Manivel JC, Copland GT et al. Immunohistochemistry of germ cell and trophoblastic neoplasms. Cancer 1988; 62: 1113-23.
100. Perlman EJ, Cushing B, Hawkins E et al. Cytogenetic analysis of childhood endodermal sinus tumor: a Pediatric Oncology Group study. Pediatr Pathol 1994; 14: 695-708.
101. Kaplan GW, Cromie WC, Kelealis PP et al. Prepubertal yolk sac testicular tumors-report of the testicular tumor registry. J Urol 1988; 140: 1109-12.
102. Kaplan WE, Firlit CF. Treatment of testicular yolk sac carcinoma in the young child. J Urol 1981: 126: 663-4.
103. Ross JH, Rybicki L, Kay R, Clinical behaviour and a contemporary management algorithm for prepubertal testis tumors: a summary of the prepubertal testis tumor registry. J Urol 2002; 168: 1675-8.
104. Ulbright TM, Young RH, Scully RE. Trophoblastic tumors of the testis other than classic choriocarcinoma: 'monophasic' choriocarcinoma and placental site trophoblastic tumor: a report of two cases. Am J Surg Pathol 1997; 21: 282-8.
105. Suurmeijer AJ, Gietema JA, Hoekstra HJ. Placental site trophoblastic tumor in a late recurrence of a nonseminomatous germ cell tumor of the testis. Am J Surg Pathol 2004; 28: 830-3.
106. Petignat P, Billieux MH, Blouin JL et al. Is genetic analysis useful in the routine management of hydatidiform mole? Hum Reprod 2003; 18: 243-9.
107. van Echten J, van Doorn LC, van der Linden HC et al. Cytogenetics of a malignant ovarian germ-cell tumor. Int J Cancer 1998; 77: 217-18.
108. Giralt SA, Dexeus F, Amato R et al. Hyperthyroidism in men with germ cell tumors and high levels of beta-human chorionic gonadotropin. Cancer 1992; 69: 1286-90.
109. Bower M, Newlands E, Holden L et al. Treatment of men with metastatic non-seminomatous germ cell tumors with cyclical POMB/ACE chemotherapy. Ann Oncol 1997; 8: 477-83.
110. Logothetis CJ, Samuels ML, Selig DE et al. Cyclic chemotherapy with cyclophosphamide, doxorubicin, and cisplatin plus vinblastine and bleomycin in advanced germinal tumors. Am J Med 1986; 81: 219-28.
111. Virchow R. Die krankhaften Geschwülste. Verlag A. Berlin, Hirschwald: 1863.
112. Pichmann S, Mikuz G, Schmid KW. Chromogranins A and B in nonseminomatous testicular tumors. J Uropathol 1993; 1: 43-54.
113. Damjanov I. Tumors of the testis and epididymis. In: Murphy WM, ed. Urological Pathology, 2nd edn. Philadelphia, (WB Saunders Company London, Toronto, Montreal, Sydney, Tokyo) 277-341.
114. Garett JE, Cartwright PC, Snow BW et al. Cystic testicular lesions in the pediatric population. J Urol 2000; 163: 928-36.
115. Ulbright TM, Srigley JR. Dermoid cyst of the testis: a study of five postpubertal cases, including a pilomatrixoma-like variant, with evidence supporting its separate classification from mature testicular teratoma. Am J Surg Pathol 2000; 25: 788-93.
116. Shah KH et al. Epidermoid cyst of the testis: a report of three cases and analysis of 141 cases from the world literature: Cancer 1981; 47: 577-82.
117. Heidenreich A, Zumbe J, Vorreuther R et al. Testikuläre Epidermiszyste: Orchiektomie oder Enuklationsresektion? Urologe A 1996; 35: 1-5.
118. Zavala-Pompa A, Ro JY, El-Naggar A et al. Primary carcinoid tumor of the testis. Immunohistochemical, ultrastructural, and DNA flow cytometric study of three cases with a review of the literature. Cancer 1993; 72: 1726-32.
119. Ulbright TM, Loehrer PJ, Roth LM et al. The development of nongerm cell malignancies within germ cell tumors. A clinicopathologic study of 11 cases. Cancer 1984; 54: 1824-33.
120. Comiter CV, Kibel AS, Richie JP et al. Prognostic features of teratomas with malignant transformation: a clinicopathological study of 21 cases. J Urol 1998; 859-63.
121. Molenaar WM, Oosterhuis JW, Meiring A et al. Histology and DNA contents of a secondary malignancy arising in a mature residual lesion six years after chemotherapy for a disseminated nonseminomatous testicular tumor. Cancer 1986; 58: 264-8.
122. Motzer RJ, Amsterdam A, Prieto V et al. Teratoma with malignant transformation: diverse malignant histologies arising in men with germ cell tumors. J Urol. 1998; 159: 133-8.
123. Grady RW, Ross JH, Kay R. Epidemiological features of testicular teratoma in a prepubertal population. J Urol 1997; 158: 1191-2.
124. Mosharafa AA, Foster RS, Leibovich BC et al. Histology in mixed germ cell tumors. Is there a favourite pairing? J Urol 2004; 171: 1471-3.
125. Freedman LS, Parkinson MC, Jones WG et al. Histopathology in the prediction of relapse of patients with stage I testicular teratoma treated by orchidectomy alone. Lancet 1987; 2: 294-8.
126. Albers P, deRiese W, Walker EB et al. Predictive parameters in biologic assessment of low-stage retroperitoneal lymph-node dissection.World J Urol 1994; 12: 120-4.
127. Ulbright TM, Orazi A, de Riese W et al. The correlation of P53 protein expression with proliferative activity and occult metastases in clinical stage I non-seminomatous germ cell tumors of the testis. Mod Pathol 1994; 7: 64-8.
128. Hildenbrand G, Weißbach L, Oberhoffer G et al. In: Weißbach L, Hildenbrand G, eds. Register und Verbundstudie für Hodentumoren- Bonn. Ergebnisse einer prospektiven Untersuchung. München: W Zuckschwerdt Verlag, 1982; 125-36.
129. Donohue JP. Metastatic pathways of non seminomatous germ cell tumors. Semin Urol 1984; 2: 217-29.
130. Sheinfeld J, Motzer RJ, Rabbani F et al. Incidence and clinical outcome of patients with teratoma in the retroperitoneum following primary retroperitoneal lymph node dissection for clinical stages I and IIA nonseminomatous germ cell tumors. J Urol 2003; 170: 1159-62.
131. Carver BS, Bianco FJ, Shayegan B et al. Predicting teratoma in the retroperitoneum in men undergoing post chemotherapy retroperitoneal lymph node dissection. J Urol 2006; 176: 100-4.
132. Michael H, Lucia J, Foster RS et al. The pathology of late recurrence of testicular germ cell tumors. Am J Surg Pathol 2000; 24: 257-73.
133. Rustin GJ, Vogelzang NJ, Sleijfer DT et al. Consensus statement on circulating tumor markers and staging patients with germ cell tumors. Prog Clin Biol Res 1990; 357: 277-84.
134. Scholz M, Zehender M, Thalmann GN et al. Extragonadal retroperitoneal germ cell tumor: evidence of origin in the testis. Ann Oncol 2002; 13: 121-4.
135. Bär W, Hedinger Chr. Ausgebrannte (okulte) Hodentumoren. Hodenläsionen bei klinisch scheinbar primär extratesticulären malignen Keimzelltumoren.Virch Arch A Path Anat Histol 1977; 377: 67-87.
136. Lopez JI, Angulo JC. Burned out tumor of the testis presenting as retroperitoneal choriocarcinoma. Int Urol Nephrol 1994; 26: 549-53.
137. Casella R, Rochlitz C, Sauter G et al. Der 'ausgebrante' Hodentumor: eine seltene Erscheinungsform der Keimzellneoplasien. Schweiz Med Wochenschr 1999; 129: 235-40.
138. Ulbright TM, Amin MB, Young RH. Tumors of the Testis, Adnexa, Spermatic Cord, and Scrotum. AFIP Atlas of Tumor Pathology, 3rd series, Fascicle 25. Washington DC, Armed Forces Institute of Pathology 1999; 193-233.
139. Algaba F, Arce Y, Lopez-Beltran A et al. European Society of Uropathology; Uropathology Working Group. Intraoperative frozen section diagnosis in urological oncology. Eur Urol. 2005; 47: 129-36.
140. Teilum G. Special Tumors of the Ovary, and Testis, 2nd edn. Munksgard, Copenhagen; 1976.
141. Kim I, Young RH, Scully RE. Leydig cell tumors of the testis. A clinicopathological analysis of 40 cases and review of the literature. Am J Surg Pathol 1985; 9: 177-92.
142. Ulbright TM, Srigley JR, Hatzianastassiou DK et al. Leydig cell tumors of the testis with unusual features: adipose differentiation, calcification with ossification, and spindle-shaped tumor cells. Am J Surg Pathol 2002; 26: 1424-33.
143. Lawrence WD, Young RH, Scully RE. Sex cord-stromal tumors. In: Talerman A, Roth LM eds. Pathology of the Testis and its Adnexa. New York, Edinburgh, London, Melbourne, Churchill Livingstone, 1986; 67-92.
144. Busam KJ, Iversen K, Coplan KA et al. Immunoreactivity for A103, an antibody to melan-A (Mart-1), in adrenocortical and other steroid tumors. Am J Surg Pathol 1998; 22: 57-63.
145. Kommoss F, Oliva E, Bittinger F et al. Inhibin-alpha CD99, HEA125, PLAP, and chromogranin immunoreactivity in testicular neoplasms and the androgen insensitivity syndrome. Hum Pathol. 2000; 31: 1055-61.
146. Mikuz G, Damjanov I. Inflammation of the testis, epididymis, peritesticular membranes, and scrotum. Pathol Annu 1982; 17: 101-28.
147. Okada H, Gotoh A, Takechi Y et al. Leydig cell tumor of the testis associated with Klinefelter's syndrome and Osgood-Schlatter disease. Br J Urol 1994; 73: 457.
148. Rutgers JL, Scully RE. Pathology of the testis in intersex syndromes. Semin Diagn Pathol 1987; 4: 275-91.
149. Mikuz G, Loewit K, Herbst M. über nebennierenrindenartige Leydig'sche Zwischenzellen.Virch Arch Abt B [Zellpath] 1975; 19: 359-68.
150. Cheville JC, Sebo TJ, Lager DJ et al. Leydig cell tumor of the testis: a clinicopathologic, DNA content and MIB-1 comparison of nonmetastasizing and metastasizing tumors. Am J Surg Pathol 1998; 22: 1361-7.
151. Grem JL, Robins HI, Wilson KS et al. Metastatic Leydig cell tumor of the testis. Report of three cases and review of the literature Cancer. 1986; 58: 2116-19.
152. Verdorfer I, Horst D, Höllrigl A et al. Leydig cell tumors of the testis. A molecular cytogenetic study based on a series of 25 patients. Oncol Rep 2007; 17: 585-9.
153. Bercovici JP, Nahoul K, Tater D et al. Hormonal profile of Leydig cell tumors with gynecomastia. J Clin Endocrinol Metab. 1984; 59: 625-63.
154. Bercovici JP, Nahoul K, Ducasse M et al. Leydig cell tumor with gynecomastia: further studies-the recovery after unilateral orchidectomy. J Clin Endocrinol Metab. 1985; 61: 957-62.
155. Konrad D, Schoenle EJ. Ten-year follow-up in a boy with Leydig cell tumor after selective surgery. Horm Res. 1999; 51: 96-100.
156. Shukla AR, Woodard C, Carr MC et al. Experience with testis sparing surgery for testicular teratoma. J Urol 2004; 171: 161-3.
157. Mosharafa AA, Bertram KA, Bratloff B et al. Treatment of malignant Leydig cell tumor. Cancer 1991; 68: 2324-9.
158. Bertram KA, Bratloff B, Hodges GF et al. Treatment of malignant Leydig cell tumor. Cancer 1991; 68: 2324-9.
159. Young RH, Koelliker DD, Scully RE. Sertoli cell tumors of the testis, not otherwise specified: a clinicopathologic analysis of 60 cases. Am J Surg Pathol 1998; 22: 709-21.
160. Young S, Gooneratne S, Straus FH et al. Feminizing Sertoli cell tumors in boys with Peutz-Jeghers syndrome. Am J Surg Pathol 1995; 19: 50-8.
161. Carney JA, Gordon H, Carpenter PC et al. The complex of myxomas, spotty pigmentation, and endocrine overactivity. Medicine (Baltimore) 1985; 64: 270-83.
162. Madsen EL, Hultberg BM. Metastasizing Sertoli cell tumors of the human testis-a report of two cases and review of the literature. Acta Oncol 1990; 29: 946-9.
163. Henley JD, Young RH, Ulbright TM. Malignant Sertoli cell tumors of the testis: a study of 13 examples of a neoplasm frequently misinterpreted as seminoma. Am J Surg Pathol 2002; 26: 541-50.
164. Zuckerberg LR, Young RH, Scully RE. Sclerosing Sertoli cell tumor of the testis: a report of 10 cases. Am J Surg Pathol 1991; 15: 829-64.
165. Hedinger CE, Plattner D. Dysgenetische, sogenannte hypoplastische Zonen in retiniertenund beidseits normal deszendierten Hoden. Pathol Microbiol 1961; 24: 227-33.
166. Jacobsen GK. Malignant Sertoli cell tumors of the testis. J Urol Pathol 1993; 1: 233-55.
167. Talerman A. Malignant Sertoli cell tumor of the testis. Cancer 1971; 28: 446-55.
168. Verdorfer I, Höllrigl A, Strasser U et al. Molecular-cytogenetic characterisation of sex cord-stromal tumors: CGH analysis in Sertoli cell tumors of the testis. Virch Arch 2007; 450: 425-31.
169. Alikasifoglu A, Gonc EN, Akcoren Z et al. Feminizing Sertoli cell tumor associated with Peutz-Jeghers syndrome. J Pediatr Endocrinol Metab 2002; 15: 449-52.
170. Demir A, önol FF, Türkeri L. Case report: malignant Sertoli cell tumor of the testis in adult. Int Urol Nephrol 2004; 35: 515-16.
171. Proppe KH, Scully RE. Large cell calcifying Sertoli cell tumor of the testis. Am J Clin Pathol 1980; 74: 607-19.
172. Kratzer SS, Ulbright TM, Talerman A et al. Large cell calcifying Sertoli cell tumor of the testis: contrasting features of six malignant and six benign tumors and a review of the literature. Am J Surg Pathol 1997; 21: 1271-80.
173. Bufo P, Pennella A, Serio G et al. Malignant large cell calcifying Sertoli cell tumor of the testis (LCCSCTT). Report of a case in an elderly man and review of the literature. Pathologica 1999; 91: 107-14.
174. Proppe KH, Dickersin GR. Large-cell calcifying Sertoli cell tumor of the testis: light microscopic and ultrastructural study. Hum Pathol 1982; 13: 1109-14.
175. Suppiah A, Musa MM, Morgan DR et al. Adult granulosa cell tumor of the testis and bony metastasis. A report of the first case of granulosa cell tumor of the testicle metastasising to bone. Urol Int. 2005; 75: 91-3.
176. Young RH, Lawrence WD, Scully RE. Juvenile granulosa cell tumor- another neoplasm associated with abnormal chromosomes and ambiguous genitalia. A report of three cases. Am J Surg Patho 1985; 19: 737-43.
177. Tanaka Y, Sasaki Y, Tachibana K et al. Testicular juvenile granulosa cell tumor in an infant with X/XY mosaicism clinically diagnosed as true hermaphroditism. Am J Surg Pathol 1994; 18: 316-22.
178. Harms D, Kock LR. Testicular juvenile granulosa cell and Sertoli cell tumors: a clinicopathological study of 29 cases from the Kiel Paediatric Tumor Registry. Virch Arch 1997; 430: 301-9.
179. Deveci MS, Deveci G, Onguru O et al. Testicular gonadal stromal fibroma: case report and review of the literature. Pathol Int 2002; 52: 326-30.
180. Renshaw AA, Gordon M, Corless CL. Immunohistochemistry of unclassified sex cord-stromal tumors of the testis with a predominance of spindle cells. Mod Pathol 1997; 10: 693-700.
181. Ulbright TM, Young RH. Primary mucinous tumors of the testis and paratestis: a report of nine cases. Am J Surg Pathol 2003; 27(9): 1221-8.
182. Scully RE. Gonadoblastoma. A gonadal tumor related to the dysgerminoma (seminoma) and capable of sex hormone production. Cancer 1953; 6: 445-63.
183. Talerman A. A distinctive gonadal neoplasm related to gonadoblastoma. Cancer 1972; 30: 1219-24.
184. Ulbright TM, Srigley JR, Reuter VE et al. Sex cord-stromal tumors of the testis with entrapped germ cells: a lesion mimicking unclassified mixed germ cell sex cord-stromal tumors. Am J Surg Pathol 2000; 24: 535-42.
185. Michal M, Vanecek T, Sima R et al. Mixed germ cell sex cord-stromal tumors of the testis and ovary. Morphological, immunohistochemical, and molecular genetic study of seven cases. Virch Arch. 2006; 448: 612-22.
186. Masson P. Pflügerome. Bull Soc Anat Paris 1912; 14: 403-4.
187. Scully RE, Gonadoblastoma. A review of 74 cases. Cancer 1970; 25: 1340-56.
188. Pohl HG, Shukla AR, Metcalf PD et al. Prepubertal testis tumors: actual prevalence rate of histological types. J Urol 2004; 172: 2370-2.
189. Cools M, Drop SL, Wolffenbuttel KP et al. Germ cell tumors in the intersex gonad: old paths, new directions, moving frontiers. Endocr Rev 2006; 27: 468-84.
190. McTaggart SJ, Algar E, Chow CW et al. Clinical spectrum of Denys-Drash and Frasier syndrome. Pediatr Nephrol 2001; 16: 335-9.
191. Saylam K, Simon P. WT1 gene mutation responsible for male sex reversal and renal failure: the frasier syndrome. Eur J Obstet Gynecol Reprod Biol 2003; 110: 111-13.
192. Kato N, Motoyama T, Kameda N et al. Primary carcinoid tumor of the testis: immunohistochemical, ultrastructural and FISH analysis with review of the literature. Pathol Int 2003; 53: 680-5.
193. Amin MB. Selected other problematic testicular and paratesticular lesions: rete testis neoplasms and pseudotumors, mesothelial lesions and secondary tumors. Mod Pathol 2005; 18 (Suppl 2): S131-45.
194. Young RH, Scully RE. Testicular and paratesticular tumors and tumorlike lesions of ovarian common epithelial and Müllerian types. Am J Clin Pathol 1986; 86: 146-52.
195. Jones MA, Young RH, Srigley JR et al. Paratesticular serous papillary carcinoma. A report of six cases. Am J Surg Pathol 1995; 19: 1359-65.
196. Ulbright TM, Young RH. Primary mucinous tumors of the testis and paratestis: a report of nine cases. Am J Surg Pathol 2003; 27: 1221-8.
197. Henley JD, Ferry J. Ulbright TM. Miscellaneous rare paratesticular tumors. Semin Diagn Pathol 2000; 17: 319-39.
198. Zucca E, Conconi A, Mughal TI et al. Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the International Extranodal Lymphoma Study Group. J Clin Oncol 2003; 21: 20-7.
199. Anghel G, Petti N, Remotti D et al. Testicular plasmacytoma: report of a case and review of the literature. Am J Hematol 2002; 71: 98-104.
200. Ferry JA, Harris NL, Young RH et al. Malignant lymphoma of the testis, epididymis, and spermatic cord. A clinicopathologic study of 69 cases with immunophenotypic analysis. Am J Surg Pathol 1994; 18: 376-90.
201. Darby S, Hancock BW. Localised non-Hodgkin lymphoma of the testis: the Sheffield Lymphoma Group experience. Int J Oncol 2005; 26: 1093-9.
202. Moller MB, d'Amore F, Christensen BE. Testicular lymphoma: a population- based study of incidence clinicopathological correlations and prognosis. The Danish Lymphoma Study Group, LYFO. Eur J Cancer 1994; 30A: 1760-4.
203. Kim YB, Chang SK, Yang WI et al. Primary NK/T cell lymphoma of the testis. A case report and review of the literature. Acta Haematol. 2003; 109: 95-100.
204. Givler RL. Testicular involvement in leukaemia and lymphoma. Cancer 1969; 23: 1290-5.
205. Miller DR, Leikin Sl, Albo VC et al. The prognostic value of testicular biopsy in childhood acute lymphoblastic leukemia: a report from the Childrens Cancer Study Group. J Clin Oncol 1990; 8: 57-66.
206. McIlwain L, Sokol L, Moscinski LC et al. Acute myeloid leukemia mimicking primary testicular neoplasm. Presentation of a case with review of literature. Eur J Haematol 2003; 70: 242-5.
207. Jones EC, Murray SK, Young RH. Cysts and epithelial proliferations of the testicular collecting system (including rete testis). Semin Diagn Pathol 2000; 17: 270-93.
208. Jones MA, Young RH, Srigley JR et al. Paratesticular serous papillary carcinoma. A report of six cases. Am J Surg Pathol 1995; 19: 1359-65.
209. Nochomovitz LE, Orenstein JM. Adenocarcinoma of the rete testis. Consolidation and analysis of 31 reported cases with a review of miscellaneous entities. J Urol Pathol 1994; 2: 1-37.
210. Pozza D, Masci P, Amodeo S et al. Papillary cystadenoma of the epididymis as a cause of obstructive azoospermia. Urol Int 1994; 53: 222-4.
211. Patel SR, Richardson RL, Kvols L. Metastatic cancer to the testes: a report of 20 cases and review of the literature. J Urol L 1989; 142: 1003-5.
212. Pienkos JE, Jablokow VR. Secondary testicular tumors. Cancer 1972; 30: 481-5.
213. Haupt HM, Mann RB, Trump DL et al. Metastatic carcinoma involving the testis. Clinical and pathologic distinction from primary testicular neoplasms. Cancer 1984; 54: 709-14.
214. Johansson JE, Lannes P. Metastases to the spermatic cord, epididymis and testicles from carcinoma of the prostate-five cases. Scand J Urol Nephrol 1983; 17: 249-51.
215. Jones MA, Young RH, Scully RE et al. Benign fibromatous tumors of the testis and paratesticular region: a report of 9 cases with a proposed classification of fibromatous tumors and tumor-like lesions. Am J Surg Pathol. 1997; 21: 296-305.
216. Banks ER, Mills SE. Histiocytoid (epithelioid) hemangioma of the testis. The so-called vascular variant of 'adenomatoid tumor'. Am J Surg Pathol 1990; 14: 584-9.
217. Washecka RM, Mariani AJ, Zuna RE et al. Primary intratesticular sarcoma. Immunohistochemical ultrastructural and DNA flow cytometric study of three cases with a review of the literature. Cancer 1996; 77: 1524-8.
218. Lee JS, Choi YD, Choi C. Primary testicular osteosarcoma with hydrocele. Virch Arch. 2004; 445: 210-13.
219. Mašera A, Ovcak Z, Mikuz G. Angiosarcoma of the testis. Virch Arch 1999; 434: 351-3.
220. Lee KC, Yeung K, Welsh C et al. Angiosarcoma following treatment of testicular seminoma: case report and literature review. J Urol 1995; 153: 1055-6.
221. Shih DF, Wang JS, Tseng HH et al. Primary squamous cell carcinoma of the testis. J Urol 1996; 156: 1772.
222. Wernert N, Goebbels R, Prediger L. Papillary cystadenoma of the epididymis. Case report and review of the literature. Pathol Res Pract 1986; 181: 260-4.
223. Gilcrease MZ, Schmidt L, Zbar B et al. Somatic von Hippel Lindau mutation in clear cell papillary cystadenoma of the epididymis. Hum Pathol 1995; 26: 1341-6.
224. Ganem JP, Jhaveri FM, Marroum MC. Primary adenocarcinoma of the epididymis: case report and review of the literature. Urology 1998; 52: 904-8.
225. Williams SB, Han M, Jones R et al. Adenomatoid tumor of the testes. Urology 2004; 63: 779-81.
226. Woodward PJ, Schwab CM, Sesterhenn IA. From the archives of the AFIP: extratesticular scrotal masses: radiologic-pathologic correlation. Radiographics 2003; 23: 215-40.
227. Janssen-Heijen ML, Damhuis RA, Klinkhamer PJ et al. Increased but low incidence and poor survival of malignant mesothelioma in the south eastern part of the Netherlands since 1970: a population-based study. Eur J Cancer Prev 1999; 8: 311-14.
228. Murai Y. Malignant mesothelioma in Japan: analysis of registered autopsy cases. Arch Environ Health 2001; 56: 84-8.
229. Plas E, Riedl CR, Pfluger H. Malignant mesothelioma of the tunica vaginalis testis. Cancer 1998; 83: 2437-46.
230. Huncharek M. Genetic factors in the aetiology of malignant mesothelioma. Eur J Cancer 1995; 31: 1741-7.
231. Eimoto T, Inoue I. Malignant fibrous mesothelioma of the tunica vaginalis. Cancer 1977; 39: 2059-66.
232. Mikuz G, Hopfel-Kreiner I. Papillary mesothelioma of the tunica vaginalis propria testis. Case report and ultrastructural study. Virch Arch A Pathol Anat Histol 1982; 396: 231-8.
233. Lane TM, Wilde M, Schofield J et al. Benign cystic mesothelioma of the tunica vaginalis. BJU Int 1999; 84: 533-4.
234. Churg A. Paratesticular mesothelial proliferations. Semin Diagn Pathol 2003; 20: 272-8.
235. Krismann M, Muller KM, Jaworska M et al. Molecular cytogenetic differences between histological subtypes of malignant mesotheliomas: DNA cytometry and comparative genomic hybridization of 90 cases. J Pathol 2002; 197: 363-71.
236. Gupta NP, Kumar R. Malignant gonadal mesothelioma. Curr Treat Options Oncol 2002; 3: 363-7.
237. Kruse-Losler B, Gaertner C, Burger H et al. Melanotic neuroectodermal tumor of infancy: systematic review of the literature and presentation of a case. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006; 102: 204-16.
238. Anagnostaki L, Krag Jacobsen G, Horn T et al. Melanotic neuroectodermal tumour as a predominant component of an immature testicular teratoma. Case report with immunohistochemical investigations. APMIS 1992; 100: 809-16.
239. Cummings OW, Ulbright TM, Young RH et al. Desmoplastic small round cell tumors of the paratesticular region. A report of six cases. Am J Surg Patholean 1997; 21: 219-25.
240. Weiss SW, Goldblum GR. Enzinger and Weiss's Soft Tissue Tumors, 4th edn. St. Louis, London, Philadelphia, Sydney, Toronto, Mosby 2001; 785-835.
241. Idrees MT, Hoch BL, Wang BY et al. Aggressive angiomyxoma of male genital region. Report of 4 cases with immunohistochemical evaluation including hormone receptor status. Ann Diagn Pathol. 2006; 10: 197-204.
242. Dahl V, Bahn RC. Aberrant adrenal cortical tissue near the testis in human infants. Am J Pathol. 1962; 40: 587-98.
243. Nistal M, Regadera J, Paniagua R et al. Cystic dysplasia of the testis. Light and electron microscopic study of three cases. Arch Pathol Lab Med. 1984; 108: 579-83.
244. Gondos B, Egli CA, Rosenthal SM et al. Testicular changes in gonadotropin-independent familial male sexual precocity. Familial testotoxicosis. Arch Pathol Lab Med 1985; 109: 990-5.
245. Mikuz G. Elektronenmikroskopische Untersuchung an zwei Fällen granulomatöser Orchitis. Virch Arch A Path Anat 1973; 360: 223-34.
246. McClure J. Malakoplakia of the testis and its relationship to granulomatous orchitis. J Clin Pathol. 1980; 33: 670-8.
247. Jones MA, Young RH, Scully RE et al. Benign fibromatous tumors of the testis and paratesticular region: a report of 9 cases with a proposed classification of fibromatous tumors and tumor-like lesions. Am J Surg Pathol 1997; 21: 296-305.
248. Seethala RR, Tirkes AT, Weinstein S et al. Diffuse fibrous pseudotumor of the testicular tunics associated with an inflamed hydrocele. Arch Pathol Lab Med. 2003; 127: 742-4.
249. Oertel YC, Johnson FB. Sclerosing lipogranuloma of male genitalia. Review of 23 cases. Arch Pathol Lab Med 1977; 101: 321-6.
250. Matsuda T, Shichiri Y, Hida S et al. Eosinophilic sclerosing lipogranuloma of the male genitalia not caused by exogenous lipids. J Urol 1988; 140: 1021-4.
251. Lowenthal SB, Goldstein AM, Terry R et al. Cholesterol granuloma of tunica vaginalis simulating testicular tumor. Urology 1981; 18: 89-90.
252. Mikuz G, Hofstadter F, Hager J et al. Testis involvement in Schonlein- Henoch purpura. Pathol Res Pract. 1979; 165: 323-9.
253. McDonald SW. Cellular responses to vasectomy. Int Rev Cytol 2000; 199: 295-339.
254. Oliva E, Young RH. Paratesticular tumor-like lesions. Semin Diagn Pathol 2000; 17: 340-58.
255. Shned AR, Selikowitz SM. Epididymitis nodosa. An epididymal lesion analogous to vasitis nodosa. Arch Pathol Lab Med. 1986; 110: 61-4.
256. Duncan WL Jr, Barraza MA. Splenogonadal fusion: a case report and review of literature. J Pediatr Surg 2005; 40: E5-E7.
257. Ferro F, Lais A, Boldrini R et al. Hepatogonadal fusion. J Pediatr Surg 1996; 31: 435-6.
258. Woodhouse JB, Delahunt B, English SF et al. Testicular lipomatosis in Cowden's syndrome. Mod Pathol. 2005; 18: 1151-6.
259. Winstanley AM, Mikuz G, Debruyne F et al. Handling and reporting of biopsy and surgical specimens of testicular cancer. Eur Urol 2004; 564-73.